Etrolizumab Population Pharmacokinetics (Pop PK) and Covariate Analysis in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

被引：0
|
作者：
Wei, Xiaohui [1 ]
Luca, Diana [1 ]
Wang, Yehong [1 ]
O'Byrne, Sharon [1 ]
Erickson, Rich [1 ]
Davis, John [1 ]
Tang, Meina [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1673
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [41] Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension
    Reinisch, Walter
    Gibson, Peter R.
    Sandborn, William
    Feagan, Brian G.
    Marano, Colleen
    Strauss, Rick
    Johanns, Jewel
    Zhang, Hongyan
    Padgett, Lakshmi
    Adedokun, Omoniyi J.
    Colombel, Jean-Frederic
    Collins, Judith
    Rutgeerts, Paul J.
    Tarabar, Dino
    GASTROENTEROLOGY, 2016, 150 (04) : S776 - S777
  • [42] Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions
    Shao, Jie
    Vetter, Marion
    Vermeulen, An
    Feagan, Brian G.
    Sands, Bruce E.
    Panes, Julian
    Xu, Zhenhua
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1418 - 1427
  • [43] Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use
    Fung, Simon
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2024, : 433 - 443
  • [44] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    Ignacio Fernandez-Blanco, J.
    Fernandez-Diaz, Guillermo
    Cara, Carlos
    Vera, Maria I.
    Olivares, David
    Taxonera, Carlos
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 731 - 737
  • [45] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert R.
    Hanauer, Stephen B.
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Lazar, Andreas
    GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
  • [46] Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
    Kim, Jae Hyun
    Cheon, Jae Hee
    GUT AND LIVER, 2016, 10 (02) : 162 - 163
  • [47] Cost-Effectiveness of Adalimumab in Moderately to Severely Active Ulcerative Colitis
    Ali, Tauseef
    Skup, Martha
    Yang, Mei
    Yang, Min
    Wu, Eric
    Mulani, Parvez
    Chao, Jingdong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S641 - S641
  • [48] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    J. Ignacio Fernández-Blanco
    Guillermo Fernández-Díaz
    Carlos Cara
    María I. Vera
    David Olivares
    Carlos Taxonera
    Digestive Diseases and Sciences, 2018, 63 : 731 - 737
  • [49] Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
    Julian Panes
    Anthony Otley
    Yuri Sanchez Gonzalez
    Kristina Fitzgerald
    Wen Zhou
    Dapo Ilo
    Triza Brion
    Muna J. Tahir
    Digestive Diseases and Sciences, 2023, 68 : 2318 - 2332
  • [50] Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
    Panes, Julian
    Otley, Anthony
    Gonzalez, Yuri Sanchez
    Fitzgerald, Kristina
    Zhou, Wen
    Ilo, Dapo
    Brion, Triza
    Tahir, Muna J. J.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2318 - 2332
12345